📊 GOCO Key Takeaways
Is GOCO a Good Investment? Thesis Analysis
GoHealth is in severe financial distress with a 54.7% revenue collapse, operating losses of $412.9M, and negative operating cash flow of $121.9M. The company carries $636.7M in debt against $37.9M equity and only $32.9M cash, leaving it vulnerable to liquidity crisis within months at current burn rates. The fundamental business model is broken with no path to profitability visible.
Fundamentals are severely impaired: revenue has halved, margins are deeply negative, and free cash flow remains sharply negative. Leverage is extreme with thin equity and negative interest coverage, elevating solvency risk despite acceptable near‑term liquidity. A credible turnaround would require material cost resets and sustained revenue stabilization not evidenced in current results.
Why Buy GOCO? Key Strengths
- Current ratio of 2.02x suggests near-term liquidity on balance sheet
- Operates in insurance distribution sector which has structural demand
- Total assets of $987.4M provide some asset base for restructuring
- Solid near-term liquidity (current and quick 2.02x)
- Meaningful revenue base (~$362M) if stabilized
- Capital-light profile (low capex) with slight YoY net loss improvement
GOCO Investment Risks to Consider
- Revenue declined 54.7% YoY indicating severe market loss or business disruption
- Operating cash burn of $121.9M annually will exhaust $32.9M cash reserves within 3 months at current rates
- Debt-to-equity ratio of 16.81x with negative interest coverage (-23.0x) makes debt service unsustainable
- Net margin of -71.1% and operating margin of -114.1% show business generates significant losses per dollar of revenue
- ROE of -678.9% indicates shareholder value destruction and potential equity dilution or wipeout
- Extreme leverage (16.8x D/E) and negative interest coverage (-23x) indicate solvency risk
- Severe revenue contraction (-54.7% YoY) with deeply negative margins
- Persistent cash burn (OCF -$121.9M; FCF -$130.2M) and very thin equity ($37.9M)
Key Metrics to Watch
- Quarterly operating cash flow trend and burn rate
- Cash balance and runway to depletion
- Revenue stabilization/growth trajectory
- Path to operating profitability and debt refinancing capacity
- Operating cash flow
- Interest coverage
GOCO Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 2.02x current ratio provides a solid financial cushion.
GOCO Profitability Ratios
GOCO vs Finance Sector
How GoHealth, Inc. compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is GOCO Overvalued or Undervalued?
Based on fundamental analysis, GoHealth, Inc. shows some fundamental concerns relative to the Finance sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
GOCO Balance Sheet & Liquidity
GOCO 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: GoHealth, Inc.'s revenue has declined by 25% over the 5-year period, indicating business contraction. The most recent EPS of $-7.19 indicates the company is currently unprofitable.
GOCO Growth Metrics (YoY)
GOCO Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $34.2M | $6.8M | $0.46 |
| Q2 2025 | $94.0M | -$26.0M | $-2.70 |
| Q1 2025 | $185.6M | -$4.4M | $-0.52 |
| Q3 2024 | $118.3M | $6.8M | $0.46 |
| Q2 2024 | $105.9M | -$26.0M | $-2.70 |
| Q1 2024 | $183.2M | -$9.2M | $-1.04 |
| Q3 2023 | $132.0M | -$23.9M | $-2.61 |
| Q2 2023 | $142.8M | -$28.9M | $-3.27 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
GOCO Capital Allocation
GOCO SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for GoHealth, Inc. (CIK: 0001808220)
📋 Recent SEC Filings
❓ Frequently Asked Questions about GOCO
What is the AI rating for GOCO?
GoHealth, Inc. (GOCO) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 88% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are GOCO's key strengths?
Claude: Current ratio of 2.02x suggests near-term liquidity on balance sheet. Operates in insurance distribution sector which has structural demand. ChatGPT: Solid near-term liquidity (current and quick 2.02x). Meaningful revenue base (~$362M) if stabilized.
What are the risks of investing in GOCO?
Claude: Revenue declined 54.7% YoY indicating severe market loss or business disruption. Operating cash burn of $121.9M annually will exhaust $32.9M cash reserves within 3 months at current rates. ChatGPT: Extreme leverage (16.8x D/E) and negative interest coverage (-23x) indicate solvency risk. Severe revenue contraction (-54.7% YoY) with deeply negative margins.
What is GOCO's revenue and growth?
GoHealth, Inc. reported revenue of $361.8M.
Does GOCO pay dividends?
GoHealth, Inc. does not currently pay dividends.
Where can I find GOCO SEC filings?
Official SEC filings for GoHealth, Inc. (CIK: 0001808220) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is GOCO's EPS?
GoHealth, Inc. has a diluted EPS of $-20.17.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is GOCO a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, GoHealth, Inc. has a STRONG SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is GOCO stock overvalued or undervalued?
Valuation metrics for GOCO: ROE of -678.9% (sector avg: 12%), net margin of -71.1% (sector avg: 25%). Compare these metrics with sector averages to assess valuation.
Should I buy GOCO stock in 2026?
Our dual AI analysis gives GoHealth, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is GOCO's free cash flow?
GoHealth, Inc.'s operating cash flow is $-121.9M, with capital expenditures of $8.2M. FCF margin is -36.0%.
How does GOCO compare to other Finance stocks?
Vs Finance sector averages: Net margin -71.1% (avg: 25%), ROE -678.9% (avg: 12%), current ratio 2.02 (avg: 1.2).